Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03840655
Other study ID # 2017PHB101-01
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 16, 2017
Est. completion date September 1, 2018

Study information

Verified date February 2019
Source Peking University People's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

T3/T4 endoscopic thoracic sympathicotomy is a widely accepted and effective treatment for primary palmar hyperhidrosis. However, sympathetic ganglions are invisible with traditional thoracoscopy and until now, the location of ganglions are confirmed by rib indirectly. The team from thoracic department of Peking University People's Hospital discovered that the sympathetic ganglions can be visualized with fluorescent thoracoscopy. Thus, investigators want to apply fluorescent thoracoscopy in sympathicotomy of palmar hyperhidrosis, to conduct a more precise operation and compare the efficiency of the novel and traditional methods.


Recruitment information / eligibility

Status Completed
Enrollment 89
Est. completion date September 1, 2018
Est. primary completion date September 1, 2018
Accepts healthy volunteers No
Gender All
Age group 16 Years to 75 Years
Eligibility Inclusion Criteria:

1. Diagnosed with primary palmar hyperhydrosis.

2. Accept surgical treatment and signed informed consent.

Exclusion Criteria:

1. Liver dysfunction.

2. Allergic to indocyanine green.

3. Can't tolerate thoracoscopic surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Near-Infrared Imaging Thoracoscopy
Sympathicotomy performed by near-infrared imaging thoracoscopy

Locations

Country Name City State
China Peking University People'S Hospital Beijing Beijing

Sponsors (2)

Lead Sponsor Collaborator
Peking University People's Hospital Beijing Municipal Science & Technology Commission

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anatomical variation of the sympathetic ganglions Record the spatial relationship between sympathetic ganglions and ribs, for example: T3/R4 represents the T3 sympathetic ganglion is located on the 4th rib. during surgery
Secondary Improvement of palmar sweating Use questionnaire including 3 descriptive names of scale ( over dry, comfortable and wet) to record the surgical effect on palmar sweating. 1 month after surgery
Secondary Degree of compensatory hyperhidrosis Use questionnaire including 4 descriptive names of scale ( none, mild, moderate and severe) to record the side effect (compensatory hyperhidrosis) of this surgery. 1 month after surgery
See also
  Status Clinical Trial Phase
Completed NCT04906655 - An Open Label Study for Palmar Hyperhydrosis Phase 2
Completed NCT02321332 - Unilateral Sequential Sympathectomy for Palmar Hyperhidrosis N/A
Active, not recruiting NCT04263623 - Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis Phase 2
Completed NCT03880266 - A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis Phase 2
Completed NCT03404570 - Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis Phase 2